Tuesday, November 10, 2026

GBP/EUR Over 2% Up In The Last 21 Sessions

GBP/EUR Over 2% Up In The Last 21 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 2.13% for the last 21 sessions. At 09:08 EST on Tuesday, 4 April, GBP/EUR (GBPEUR) is $1.15.

GBP/EUR's yearly highs and lows, it's 5.891% up from its 52-week low and 5.512% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GBP/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd sellers attack 1.0800 as risk aversion joins consolidation ahead of US pmi, NFP. According to FXStreet on Monday, 3 April, "A clear downside break of a two-week-long ascending support line, now immediate resistance near 1.0910, directs EUR/USD bears towards the 50-DMA support of around 1.0730."
  • Eur/usd: bulls would probably welcome the pair ending the week around 1.0850/1.0900 – ING. According to FXStreet on Monday, 3 April, "We had called for EUR/USD to break above 1.10 sometime this week, but the asymmetrically positive impact on the USD of the OPEC+ surprise cut means that such a call now likely requires some disappointing data out of the US, given the lack of Euro-specific drivers this week. ", "This is not necessarily our base case, and EUR/USD bulls would probably welcome the pair ending the week around 1.0850/1.0900."
  • Eur/usd forex signal: double-top pattern forms - 03 April 2023. According to DailyForex on Monday, 3 April, "The EUR/USD pair erased some of the gains it made in March as traders started positioning for the new month. ", "The EUR/USD exchange rate pulled back on Monday morning, continuing the sell-off that started on Friday. "
  • Eur/usd reclaims 1.0900 after a v-shape recovery inspired by weak US manufacturing PMI. According to FXStreet on Monday, 3 April, "The EUR/USD pair has recaptured the round-level resistance of 1.0900 in the early Asian session. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com